GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $65,000 | +85.7% | 300 | 0.0% | 0.03% | +73.3% |
| Q4 2020 | $35,000 | +20.7% | 300 | 0.0% | 0.02% | +15.4% |
| Q3 2020 | $29,000 | +16.0% | 300 | +50.0% | 0.01% | +8.3% |
| Q2 2020 | $25,000 | -3.8% | 200 | -33.3% | 0.01% | -25.0% |
| Q1 2020 | $26,000 | -16.1% | 300 | 0.0% | 0.02% | +6.7% |
| Q4 2019 | $31,000 | -32.6% | 300 | -25.0% | 0.02% | -31.8% |
| Q3 2019 | $46,000 | -33.3% | 400 | 0.0% | 0.02% | -35.3% |
| Q2 2019 | $69,000 | +3.0% | 400 | 0.0% | 0.03% | 0.0% |
| Q1 2019 | $67,000 | +71.8% | 400 | 0.0% | 0.03% | +61.9% |
| Q4 2018 | $39,000 | -25.0% | 400 | +33.3% | 0.02% | -19.2% |
| Q3 2018 | $52,000 | +271.4% | 300 | +200.0% | 0.03% | +271.4% |
| Q2 2018 | $14,000 | +27.3% | 100 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $11,000 | +37.5% | 100 | +66.7% | 0.01% | +50.0% |
| Q4 2017 | $8,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |